[Prophylactic medical investigations for breast cancer and uterine cervix cancer in Regional Oncology Centre of Bydgoszcz in 2003].
Kujawsko-pomorskie province is a region with high morbidity and death rate of breast cancer and uterine cervix cancer. Prophylactic medical investigations are methods to find less advanced forms as possible. The aim of the study was to estimate the results of prophylactic medical investigations of Regional Oncology Centre in Bydgoszcz in 2003. Mammography investigations were undertaken in 3 forms. The first one--so called "mobile"--was localized in chosen health service centres, the second one in "mammo-bus" reaching distant communes and the third one local outpatient clinics. Cytological investigations were rated by Bethesda and Papanicolau system. 23 923 people were investigated for breast cancer (age 35-79) and 7946 ones for uterine cervix cancer (age 30-74). 9183 medical investigations were taken by "mobile" device, 4592 in "mammo-bus" and 10 148 locally. 11 986 people had breast examinations, 6118 had gynaecologic examinations. There were cytological investigations results: I group--3902, II group--4019, III group--21, IV group--3, V group--1. Ten uterine cervix cancers were diagnosed (0.13% of investigated population). Five of them were histologically recognised as: carcinoma planoepitheliale praeinvasivum. 91 cases of breast cancers were diagnosed (0.38% of investigated population). Five of them were histologically recognised as: carcinoma intraductale typus comedo (there were: 3 simplex mastectomy, 2 tumorectomy with radiotherapy). The treatment of invasive cancers included 9 breast-conserving treatments.


CONCLUSIONS
Prophylactic medical investigations let us find the cancer in early development stage and a number of cancer detections is a justification of this project continuation. The possibility to examine women from villages should have the influence on the detection of early breast and uterine cervix cancer.
Mierzwa
Tomasz
T
Z Zakładu Profilaktyki i Promocji Zdrowia Centrum Onkologii im. Prof. F. Lukaszczyka w Bydgoszczy. mierzwatomasz@wp.pl
Grabiec
Marek
M
D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D005260:Female; D006293:Health Promotion / Q000592:standards*; D006801:Humans; D008403:Mass Screening / Q000379:methods / Q000706:statistics & numerical data*; D008875:Middle Aged; D009367:Neoplasm Staging; D011044:Poland / Q000453:epidemiology; D011230:Precancerous Conditions / Q000517:prevention & control; D011322:Primary Prevention / Q000379:methods; D012307:Risk Factors; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D002583:Uterine Cervical Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control*; D014626:Vaginal Smears / Q000379:methods / Q000706:statistics & numerical data; D016387:Women's Health